It has been suggested that the distribution and biochemical composition of amyloid-beta (Aβ) plaques and phosphorylated tau (p-tau)-immunoreactive neurofibrillary tangles (NFTs) in DS individuals with AD-type pathology are similar to those in familial and sporadic AD (sAD) [5,6]. This evidence concerns the gene MAPT and Alzheimer disease.